Non-Islet Cell Tumor Hypoglycemia in Metastatic Breast Adenocarcinoma: Resolution Following Transition to Elacestrant Therapy
AACE Endocrinology and Diabetes · 2026-09
DOI: 10.1016/j.aed.2026.09.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-09. Verfasst von Payton Schultz und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Schultz, P., Iqbal, A., & Trost, S. (2026). Non-Islet Cell Tumor Hypoglycemia in Metastatic Breast Adenocarcinoma: Resolution Following Transition to Elacestrant Therapy. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.09.008
Vancouver
Schultz P, Iqbal A, Trost S. Non-Islet Cell Tumor Hypoglycemia in Metastatic Breast Adenocarcinoma: Resolution Following Transition to Elacestrant Therapy. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.09.008
BibTeX
@article{Schultz2026,
author = {Schultz, Payton and Iqbal, Aimen and Trost, Susanne},
title = {Non-Islet Cell Tumor Hypoglycemia in Metastatic Breast Adenocarcinoma: Resolution Following Transition to Elacestrant Therapy},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.09.008}
}
EUVIMED